IDXX
IDEXX Laboratories, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website idexx.com
- Employees(FY) 11000
- ISIN US45168D1046
Performance
-1.76%
1W
-8.55%
1M
-15.77%
3M
-22.97%
6M
-24.58%
YTD
-11.49%
1Y
Profile
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Technical Analysis of IDXX 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-19 09:00
IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet(Simply Wall St.)
- 2024-11-15 08:00
- 2024-11-12 19:00
IDXX: Raising target price to $447.00(Argus Research)
- 2024-11-10 07:00
- 2024-11-07 08:44
- 2024-11-06 09:00
- 2024-11-06 04:11
- 2024-11-05 19:00
IDXX: Lowering target price to $437.00(Argus Research)
- 2024-11-05 09:53
- 2024-11-04 10:50
- 2024-11-04 09:03
- 2024-11-01 13:24
- 2024-11-01 09:46
- 2024-11-01 09:46
- 2024-11-01 09:46
- 2024-11-01 09:46
- 2024-11-01 03:05
- 2024-11-01 03:01
Q3 2024 IDEXX Laboratories Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-10-31 13:16
Analyst Report: IDEXX Laboratories, Inc.(Morningstar Research)
- 2024-10-31 11:07
- 2024-10-31 09:30
- 2024-10-31 08:00
- 2024-10-31 07:40
- 2024-10-31 07:35
- 2024-10-31 06:41
Idexx: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-10-31 06:30
IDEXX Laboratories Announces Third Quarter Results(Business Wire)
- 2024-10-30 18:30
IDEXX Laboratories Announces Third Quarter Results(Businesswire)
- 2024-10-28 09:16
- 2024-10-25 10:00
- 2024-10-24 10:01
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.